OR WAIT null SECS
© 2022 MJH Life Sciences and Rheumatology Network. All rights reserved.
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
The US Food and Drug Administration (FDA) announced it has authorized a third dose of either the Pfizer/BioNTech or Moderna mRNA COVID-19 vaccines for patients with compromised immune systems, such as patients with rheumatic disease.